Compositions contain (i) ranitidine bismuth citrate and (ii) a non-steroidal anti-inflammatory drug for treating or preventing inflammatory conditions and for analgesia. Exemplified as the NSAID are indomethacin or ibuprofen.

FIELD: medicine, pharmacy. SUBSTANCE: invention relates to drugs, a combined preparation, a pharmaceutical composition and a method for prophylaxis or treatment of inflammatory states or analgesia. Drug for treatment or prophylaxis of damage of gastroenteric tract caused by nonsteroid anti-inflammatory drugs is ranitidine bismuth-citrate or a pharmaceutical composition containing its. Combined preparation for treatment or prophylaxis of inflammatory states or for analgesia in human or animals ha...

The invention relates to an aqueous pharmaceutical composition for oral administration comprising ranitidine, or a pharmaceutically acceptable salt thereof, characterised in that the composition contains low colour, metal, turbidity (LCMT) sucrose.

The invention relates to an aqueous pharmaceutical composition for oral administration comprising ranitidine, or a pharmaceutically acceptable salt thereof, characterised in that the composition contains low colour, metal, turbidity (LCMT) sucrose.

The composition is in solid form for single dosing and issuitable for oral application. It contains salt formed fromranitidine and a complex of bismuth with carboxylic acid, selectedfrom tartaric or citric acids, together with alkaline salt. Thecomposition is in the form of tablets, containingranitidinebismuth citrate and sodium carbonate. The compositionmanifests an improved degree of decomposition and/or dissolutionand finds application in human medicine, blocking the H2-receptorsin the stomac...